IP Library Granted Patent US 12,702,420
Granted Patent B2
US 12,702,420 · App. 18/119,766 · Granted Aug 11, 2026

Vaso-occlusive devices and methods of use

Inventors: Michael P. Wallace (Pleasanton, CA); E. Skott Greenhalgh (Gladwyne, PA)
Assignee: Stryker European Operations Holdings LLC
A61B17/12113A61B17/1204A61B17/1214A61B17/1215A61B17/12172A61B17/12177A61F2/07A61B2017/00526A61B2017/00845A61B2017/00858A61B2017/00867A61B2017/00893A61B2017/00898A61B2017/1205
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,702,420
App. No.
18/119,766
Granted
Aug 11, 2026
Kind
B2
Abstract

Vaso-occlusive apparatuses, including implants, and methods of using them to treat aneurysms. For example, described herein are expandable vaso-occlusive implants that include one or more soft and expandable braided member coupled to a pushable member such as a coil that maybe inserted and retrieved from within an aneurism using a delivery catheter. In particular, the expandable implants described herein are configured to allow relatively soft and elongate implants to be pushed out of a cannula without binding up within the cannula.

Claims (32)

1 . A vaso-occlusive device for occluding an aneurysm, comprising:

an elongate inner member having a proximal end and a distal end; and

a plurality of distally-open, adjacently arranged braided tubular members disposed over the inner member such that the inner member extends through a lumen of each braided tubular member, each braided tubular member having a proximal end and a distal end wherein the proximal end of each braided tubular member is fixed to the inner member at longitudinally spaced apart locations along the inner member and the distal end of each braided tubular member is not attached to the inner member, each braided tubular member having a proximal portion comprising a conical shaped portion which tapers outward from the proximal end towards the distal end of the braided tubular member to a distal end of the proximal portion and a distal portion connected to, and extending from, the distal end of the proximal portion and comprising a cylindrical shaped portion wherein the cylindrical shaped portion of the distal portion has a longer length than the conical shaped portion of the proximal portion;

wherein the inner member comprises a closed pitch coil having a proximal end adjacent to the proximal end of one of the braided tubular members;

wherein each of the braided tubular members has a radially collapsed configuration having a collapsed diameter when radially constrained within a delivery catheter, and a radially expanded configuration having an expanded diameter when released from the delivery catheter, wherein the expanded diameter is greater than the collapsed diameter; and

wherein the braided tubular members comprise braided strands forming pores between the braided strands, and in the radially expanded configuration, the pores have a pore size of less than 0.06 mm 2 such that the pores block blood from passing through the pores.

2 . The vaso-occlusive device of claim 1 , wherein the inner member is a pusher member configured to push the braided tubular members longitudinally out of the delivery catheter.

3 . The vaso-occlusive device of claim 2 , wherein the inner member comprises a closed pitch coil.

4 . The vaso-occlusive device of claim 1 , wherein each of the braided tubular members is formed from about 24 to 36 strands.

5 . The vaso-occlusive device of claim 4 , wherein braid angles formed between crossing strands of the braided tubular member in a direction of the longitudinal axis are about 35 degrees or less when the braided tubular member is held in a collapsed configuration within the delivery catheter.

6 . The vaso-occlusive device of claim 1 , wherein each of the braided tubular members is adjacently arranged longitudinally along the inner member such that the distal ends of each of the braided tubular members is non-overlapping with the proximal ends of an adjacent braided tubular member.

7 . The vaso-occlusive device of claim 1 , wherein the plurality of braided tubular members comprises at least 3 braided tubular members.

8 . The vaso-occlusive device of claim 1 , wherein each braided tubular member has a length of between 5 cm and 45 cm.

9 . The vaso-occlusive device of claim 1 , wherein the proximal end of each braided tubular member comprises a stress relief transition between the braided tubular member and the fixing to the inner member, the stress relief transition comprising one of: (a) an increase in a number of braided filaments bound to the proximal end; (b) an increase in diameter of one or more braid filaments in the proximal end relative to the other filaments; (c) additional filaments bonded, sutured, or tied to the proximal end.

10 . The vaso-occlusive device of claim 1 , wherein the proximal end of at least one of the braided tubular members is formed into a helical coil structure and the helical coil structure is attached to the inner member.

11 . A vaso-occlusion system for occluding an aneurysm, the system comprising:

a delivery catheter having a proximal end and a distal end having a distal end opening; and

a vaso-occlusive device adapted to be pushed out of, and retrieved back into, the distal end opening of the delivery catheter, the vaso-occlusive device comprising

an elongate inner member having a proximal end and a distal end, and

a plurality of distally-open, adjacently arranged braided tubular members disposed over the inner member such that the inner member extends through a lumen of each braided tubular member, each braided tubular member having a proximal end and a distal end wherein the proximal end of each braided tubular member is fixed to the inner member at longitudinally spaced apart locations along the inner member and the distal end of each braided tubular member is not attached to the inner member, each braided tubular member having a proximal portion comprising a conical shaped portion which tapers outward from the proximal end towards the distal end of the braided tubular member to a distal end of the proximal portion and a distal portion connected to, and extending from, the distal end of the proximal portion and comprising a cylindrical shaped portion wherein the cylindrical shaped portion of the distal portion has a longer length than conical shaped portion of the proximal portion,

wherein the inner member comprises a closed pitch coil having a proximal end adjacent to the proximal end of one of the braided tubular members;

wherein each of the braided tubular members has a radially collapsed configuration having a collapsed diameter when radially constrained within a delivery catheter and a radially expanded configuration having an expanded diameter when released from the delivery catheter, wherein the expanded diameter is greater than the collapsed diameter, and

wherein the braided tubular members comprise braided strands forming pores between the braided strands, and in the radially expanded configuration, the pores have a pore size of less than 0.06 mm 2 such that the pores block blood from passing through the pores.

12 . The vaso-occlusive system of claim 11 , wherein the inner member is a pusher member configured to push the braided tubular members longitudinally out of the delivery catheter.

13 . The vaso-occlusive system of claim 12 , wherein the inner member comprises a closed pitch coil.

14 . The vaso-occlusive system of claim 11 , wherein each of the braided tubular members is formed from about 24 to 36 strands.

15 . The vaso-occlusive system of claim 14 , wherein braid angles formed between crossing strands of the braided tubular member in a direction of the longitudinal axis are about 35 degrees or less when the braided tubular member is held in a collapsed configuration within the delivery catheter.

16 . The vaso-occlusive system of claim 11 , wherein each of the braided tubular members is adjacently arranged longitudinally along the inner member such that the distal ends of each of the braided tubular members is non-overlapping with the proximal ends of an adjacent braided tubular member.

17 . The vaso-occlusive system of claim 11 , wherein the plurality of braided tubular members comprises at least 3 braided tubular members.

18 . The vaso-occlusive system of claim 11 , wherein each braided tubular member has a length of between 5 cm and 45 cm.

19 . The vaso-occlusive system of claim 11 , wherein the proximal end of each braided tubular member comprises a stress relief transition between the braided tubular member and the fixing to the inner member, the stress relief transition comprising one of: (a) an increase in a number of braided filaments bound to the proximal end; (b) an increase in diameter of one or more braid filaments in the proximal end relative to the other filaments; (c) additional filaments bonded, sutured, or tied to the proximal end.

20 . The vaso-occlusive device of claim 11 , wherein the proximal end of at least one of the braided tubular members is formed into a helical coil structure and the helical coil structure is attached to the inner member.

Assignments (6)
CHANGE OF ADDRESS Recorded Dec 18, 2024
From: STRYKER EUROPEAN OPERATIONS HOLDINGS LLC
To: STRYKER EUROPEAN OPERATIONS HOLDINGS LLC
Reel/Frame 069730/0754 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE PREVIOUSLY RECORDED ON REEL 063665 FRAME 0890. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded May 18, 2023
From: STRYKER EUROPEAN HOLDINGS III, LLC
To: STRYKER EUROPEAN OPERATIONS HOLDINGS LLC
Reel/Frame 063697/0371 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 16, 2023
From: WALLACE, MICHAEL P.; GREENHALGH, E. SKOTT
To: TW MEDICAL TECHNOLOGIES, LLC
Reel/Frame 063659/0132 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 16, 2023
From: TW MEDICAL TECHNOLOGIES, LLC
To: STRYKER EUROPEAN HOLDINGS I, LLC
Reel/Frame 063660/0049 →
NUNC PRO TUNC ASSIGNMENT Recorded May 16, 2023
From: STRYKER EUROPEAN HOLDINGS I, LLC
To: STRYKER EUROPEAN HOLDINGS III, LLC
Reel/Frame 063665/0074 →
CHANGE OF NAME Recorded May 16, 2023
From: STRYKER EUROPEAN HOLDINGS III, LLC
To: STRYKER EUROPEAN OPERATION HOLDINGS LLC
Reel/Frame 063665/0890 →
Continuity (5)
Continuation 16536787 · Aug 9, 2019
Continuation 15312048 · May 28, 2015
Continuation 14289555 · May 28, 2014
Provisional Application 62159154 · May 8, 2015
Related Publication 20230210534A1 · Jul 6, 2023
References Cited (166)
US 4655771A · Wallsten · 1987 [cited by applicant]
US 4754685A · Kite et al. · 1988 [cited by applicant]
US 4820298A · Leveen et al. · 1989 [cited by applicant]
US 4870887A · Tresslar et al. · 1989 [cited by applicant]
US 4994069A · Ritchart et al. · 1991 [cited by applicant]
US 5186992A · Kite · 1993 [cited by applicant]
US 5217484A · Marks et al. · 1993 [cited by applicant]
US 5304194A · Chee et al. · 1994 [cited by applicant]
US 5382259A · Phelps et al. · 1995 [cited by applicant]
US 5423849A · Engelson et al. · 1995 [cited by applicant]
US 5536274A · Neuss · 1996 [cited by applicant]
US 5639277A · Mariant et al. · 1997 [cited by applicant]
US 5690666A · Berenstein et al. · 1997 [cited by applicant]
US 5690667A · Gia · 1997 [cited by applicant]
US 5792157A · Mische et al. · 1998 [cited by applicant]
US 5888201A · Stinson et al. · 1999 [cited by applicant]
US 5891191A · Stinson · 1999 [cited by applicant]
US 5964797A · Ho · 1999 [cited by applicant]
US 5976162A · Doan et al. · 1999 [cited by applicant]
US 6007574A · Pulnev et al. · 1999 [cited by applicant]
US 6019786A · Thompson · 2000 [cited by applicant]
US 6024754A · Engelson · 2000 [cited by applicant]
US 6066158A · Engelson et al. · 2000 [cited by applicant]
US 6096052A · Callister et al. · 2000 [cited by applicant]
US 6165178A · Bashiri et al. · 2000 [cited by applicant]
US 6187027B1 · Mariant et al. · 2001 [cited by applicant]
US 6193728B1 · Ken et al. · 2001 [cited by applicant]
US 6203547B1 · Nguyen et al. · 2001 [cited by applicant]
US 6238403B1 · Green, Jr. et al. · 2001 [cited by applicant]
US 6254592B1 · Samson et al. · 2001 [cited by applicant]
US 6287318B1 · Villar et al. · 2001 [cited by applicant]
US 6350270B1 · Roue · 2002 [cited by applicant]
US 6361545B1 · Macoviak et al. · 2002 [cited by applicant]
US 6458119B1 · Berenstein et al. · 2002 [cited by applicant]
US 6475227B2 · Burke et al. · 2002 [cited by applicant]
US 6551340B1 · Konya et al. · 2003 [cited by applicant]
US 6589256B2 · Forber · 2003 [cited by applicant]
US 6592617B2 · Thompson · 2003 [cited by applicant]
US 6632241B1 · Hancock et al. · 2003 [cited by applicant]
US 6660020B2 · Wallace et al. · 2003 [cited by applicant]
US 6682546B2 · Amplatz et al. · 2004 [cited by applicant]
US 6860893B2 · Wallace et al. · 2005 [cited by applicant]
US 6866677B2 · Douk et al. · 2005 [cited by applicant]
US 6872218B2 · Ferrera et al. · 2005 [cited by applicant]
US 6974475B1 · Wall · 2005 [cited by applicant]
US 6984240B1 · Ken et al. · 2006 [cited by applicant]
US 6994689B1 · Azizi et al. · 2006 [cited by applicant]
US 7066946B2 · Douk et al. · 2006 [cited by applicant]
US 7128752B2 · Bales · 2006 [cited by applicant]
US 7323001B2 · Clubb et al. · 2008 [cited by applicant]
US 7326225B2 · Ferrera et al. · 2008 [cited by applicant]
US 7749242B2 · Tran et al. · 2010 [cited by applicant]
US 7828816B2 · Mazzocchi et al. · 2010 [cited by applicant]
US 7879062B2 · Galdonik et al. · 2011 [cited by applicant]
US 8002789B2 · Ramzipoor et al. · 2011 [cited by applicant]
US 8016852B2 · Ho et al. · 2011 [cited by applicant]
US RE43311E · Wallace et al. · 2012 [cited by applicant]
US 8172862B2 · Wallace et al. · 2012 [cited by applicant]
US 8182506B2 · Fitz et al. · 2012 [cited by applicant]
US 8361138B2 · Adams · 2013 [cited by applicant]
US 8414635B2 · Hyodoh et al. · 2013 [cited by applicant]
US 8444668B2 · Jones et al. · 2013 [cited by applicant]
US 8486104B2 · Samson et al. · 2013 [cited by applicant]
US 8603128B2 · Greene et al. · 2013 [cited by applicant]
US 8715314B1 · Janardhan et al. · 2014 [cited by applicant]
US 8715316B1 · Janardhan et al. · 2014 [cited by applicant]
US 8715317B1 · Janardhan et al. · 2014 [cited by applicant]
US 8777974B2 · Amplatz et al. · 2014 [cited by applicant]
US 9011482B2 · Wallace et al. · 2015 [cited by applicant]
US 9060777B1 · Wallace et al. · 2015 [cited by applicant]
US 9211396B2 · Aboytes · 2015 [cited by applicant]
US 9907557B2 · Wallace et al. · 2018 [cited by applicant]
US 10159490B2 · Wallace et al. · 2018 [cited by applicant]
US 10383635B2 · Wallace et al. · 2019 [cited by applicant]
US 20020058992A1 · Greenhalgh · 2002 [cited by applicant]
US 20030093111A1 · Ken et al. · 2003 [cited by applicant]
US 20030153943A1 · Michael · 2003 [cited by examiner]
US 20040098023A1 · Lee et al. · 2004 [cited by applicant]
US 20040199246A1 · Chu et al. · 2004 [cited by applicant]
US 20050137696A1 · Salahieh · 2005 [cited by examiner]
US 20050222605A1 · Greenhalgh et al. · 2005 [cited by applicant]
US 20050267510A1 · Razack · 2005 [cited by applicant]
US 20050277978A1 · Greenhalgh · 2005 [cited by applicant]
US 20060009799A1 · Kleshinski et al. · 2006 [cited by applicant]
US 20060030876A1 · Peacock et al. · 2006 [cited by applicant]
US 20060116709A1 · Sepetka et al. · 2006 [cited by applicant]
US 20060116713A1 · Sepetka et al. · 2006 [cited by applicant]
US 20060276886A1 · George · 2006 [cited by examiner]
US 20070208373A1 · Zaver · 2007 [cited by examiner]
US 20070233186A1 · Meng · 2007 [cited by applicant]
US 20070233224A1 · Leynov et al. · 2007 [cited by applicant]
US 20080071356A1 · Greenhalgh et al. · 2008 [cited by applicant]
US 20080097401A1 · Trapp et al. · 2008 [cited by applicant]
US 20080109057A1 · Calabria et al. · 2008 [cited by applicant]
US 20090093873A1 · Navia · 2009 [cited by applicant]
US 20090105748A1 · Fogarty et al. · 2009 [cited by applicant]
US 20090112251A1 · Qian et al. · 2009 [cited by applicant]
US 20090210047A1 · Amplatz et al. · 2009 [cited by applicant]
US 20090266366A1 · Swann et al. · 2009 [cited by applicant]
US 20090297582A1 · Meyer et al. · 2009 [cited by applicant]
US 20100063578A1 · Ren et al. · 2010 [cited by applicant]
US 20100152766A1 · Dieck et al. · 2010 [cited by applicant]
US 20100228278A1 · Tran et al. · 2010 [cited by applicant]
US 20110196414A1 · Porter · 2011 [cited by examiner]
US 20110213405A1 · Porter et al. · 2011 [cited by applicant]
US 20120158034A1 · Wilson et al. · 2012 [cited by applicant]
US 20120172920A1 · Fifer · 2012 [cited by examiner]
US 20120259404A1 · Tieu et al. · 2012 [cited by applicant]
US 20130112070A1 · Mach · 2013 [cited by applicant]
US 20130116722A1 · Aboytes et al. · 2013 [cited by applicant]
US 20130253572A1 · Molaei et al. · 2013 [cited by applicant]
US 20130267992A1 · Tran et al. · 2013 [cited by applicant]
US 20130274849A1 · Zaver et al. · 2013 [cited by applicant]
US 20130345739A1 · Brady · 2013 [cited by examiner]
US 20140135810A1 · Divino et al. · 2014 [cited by applicant]
US 20140135827A1 · Amplatz et al. · 2014 [cited by applicant]
US 20140277099A1 · Wallace et al. · 2014 [cited by applicant]
US 20140303667A1 · Cox · 2014 [cited by examiner]
US 20140330229A1 · Rosenbluth et al. · 2014 [cited by applicant]
US 20150343181A1 · Bradway et al. · 2015 [cited by applicant]
US 20170008685A1 · Stever et al. · 2017 [cited by applicant]
US 20180250013A1 · Wallace et al. · 2018 [cited by applicant]
US 20190201000A1 · Wallace et al. · 2019 [cited by applicant]
CN 102368963 · 2012 [cited by applicant]
WO WO9939646 · 1999 [cited by applicant]
WO WO2003082363 · 2003 [cited by applicant]
WO WO2004045425 · 2004 [cited by applicant]
WO WO2005065556 · 2005 [cited by applicant]
WO WO2007041624 · 2007 [cited by applicant]
WO WO2010135352 · 2010 [cited by applicant]
WO WO2013082555 · 2013 [cited by examiner]
WO WO2013102848 · 2013 [cited by applicant]
WO WO2007123638 · 2013 [cited by applicant]
WO WO2013119332 · 2013 [cited by applicant]
WO WO2014144980 · 2014 [cited by applicant]
WO WO2015184075 · 2015 [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 16/536,787 dated Oct. 6, 2022. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 16/536,787 dated Apr. 28, 2022. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 16/536,787 dated Oct. 28, 2021. [cited by applicant]
Final Office Action for U.S. Appl. No. 16/536,787 dated Sep. 8, 2022. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 16/536,787 dated Dec. 14, 2022. [cited by applicant]
Amendment Response to NFOA for U.S. Appl. No. 16/536,787 dated Oct. 31, 2022. [cited by applicant]
Amendment Response to NFOA for U.S. Appl. No. 16/536,787 dated May 25, 2022. [cited by applicant]
Amendment Response to NFOA for U.S. Appl. No. 16/536,787 dated Dec. 27, 2021. [cited by applicant]
Amendment Response to FOA for U.S. Appl. No. 16/536,787 dated Sep. 28, 2022. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 17/182,194 dated Dec. 15, 2022. [cited by applicant]
Examination Report dated Feb. 25, 2019 for European Application No. 15798783.5, Applicant Stryker European Holdings I, LLC, 4 pages. [cited by applicant]
Decision of Rejection issued on Oct. 9, 2018 for Chinese application No. 201580027802.4 in Chinese with English language translation provided by Chinese associate, 11 pages. [cited by applicant]
Notification of First Office Action issued on Sep. 26, 2017 for Chinese application No. 201580027802.4 in Chinese with English language translation provided by Chinese associate, 15 pages. [cited by applicant]
Notification of Second Office Action issued on May 31, 2018 for Chinese application No. 201580027802.4 in Chinese with English language translation provided by Chinese associate, 14 pages. [cited by applicant]
Extended European Search Report mailed Apr. 3, 2017 for EP Application No. 15798783.5, Applicant Stryker European Holdings I, LLC, 9 pages. [cited by applicant]
Notice of Rejection mailed May 30, 2017 for Japanese Patent Application No. 2016-569451, Applicant Stryker European Holdings I, LLC, 8 pages. [cited by applicant]
PCT International Search Report and Written Opinion dated Sep. 3, 2015 for International Appln. No. PCT/US15/32847, Applicant TW Medical Technologies, LLC, forms PCT/ISA/210, 220, and 237,(19 pages). [cited by applicant]
Walton et al, Inhibition of Prostaglandin E2 Synthesis in Abdominal Aortic Aneurysms, Circulation, Jul. 6, 1999, 48-54 (8 pages). [cited by applicant]
Tambiah et al, Provocation of Experimental Aortic Inflammation and Dilatation by Inflammatory Mediators and Chlamydia Pneumoniae, Brit. J. Surgery 88 (7), 935-940, Feb. 2001. [cited by applicant]
Franklin et al, Uptake of Tetracycline by Aortic Aneurysm Wall and Its Effect on Inflammation and Proteolysis, Brit. J. Surgery 86 (6), 771-775, Feb. 1999. [cited by applicant]
Xu et al, Sp1 Increases Expression of Cyclooxygenase-2 in Hypoxic Vascular Endothelium, J. Biological Chemistry 75 (32) 24583-24589, Aug. 11, 2000 (8 pages). [cited by applicant]
Pyo et al., Targeted Gene Disruption of Matrix Metalloproteinase-9 (Gelatinase B) Suppresses Development of Experimental Abdominal Aortic Aneurysms, J. Clinical Investigation 105 (11), pp. 1641-1649, Jun. 2000. [cited by applicant]
Non Final Office Action mailed Sep. 25, 2018 for U.S. Appl. No. 15/312,048, 10 pages. [cited by applicant]
PCT International Search Report for International Appln. No. PCT/US2013/000033, Applicant TW Medical Technologies LLC, dated Sep. 8, 2013 (11 pages). [cited by applicant]
PCT International Search Report and Written Opinion for International Application No. PCT/US2016/031323 , Applicant Stryker European Holdings I, LLC, forms PCT/ISA/210, 220, and 237, dated Jul. 25, 2016 (13 pages). [cited by applicant]
Response to Extended European Search Report filed Nov. 6, 2017 for European Patent Application No. 15798783.5. [cited by applicant]
Office Action mailed Aug. 14, 2019 for Chinese patent application No. 2015800278024, including English translation provided by the foreign associate. [cited by applicant]
Response to Office Action filed Dec. 21, 2018 for U.S. Appl. No. 15/312,048, 10 pages. [cited by applicant]
Non Final Office Action mailed May 3, 2018 for U.S. Appl. No. 15/148,872, 10 pages. [cited by applicant]
Response to Office Action filed May 30, 2018 for U.S. Appl. No. 15/148,872, 5 pages. [cited by applicant]